Literature DB >> 184056

Herpes simplex type II vaccine: the favorable European experience.

T Nasemann.   

Abstract

Mesh：

Substances：

Year:  1976        PMID： 184056     DOI： 10.1111/j.1365-4362.1976.tb04893.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  3 in total

1.  [The lymphocyte transformation test in patients with recurrent herpes simplex diseases (author's transl)].

Authors:  S W Wassilew; I Koch
Journal:  Arch Dermatol Res       Date:  1978-08-28       Impact factor: 3.017

2.  Vaccination for herpes simplex genitalis.

Authors:  T Nasemann; S W Wassilew
Journal:  Br J Vener Dis       Date:  1979-04

3.  Animal studies on the efficacy of vaccination against recurrent herpes.

Authors:  M Scriba
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.